SCHEMBL8204166

SCHEMBL8204166

Clc1cc(Cl)cc(N2CC[CH]CC2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 2/20 0.59
CHRM2 P08172 1/20 0.59
CHRM4 P08173 1/20 0.59
CHRM1 P11229 1/20 0.59
CHRM3 P20309 1/20 0.59
NOTUM Q6P988 1/20 0.43
FFAR1 O14842 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
HTR3E A5X5Y0 2/20 0.38
HTR3B O95264 2/20 0.38
HTR3A P46098 2/20 0.38
HTR3D Q70Z44 2/20 0.38
HTR3C Q8WXA8 2/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
HTR1A P08908 1/20 0.38
CYP2D6 P10635 1/20 0.38
THRB P10828 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11068888 0.85 ADRB1 (0.70) ADRB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL4070205 0.79 HTR3E (0.65) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL4074886 0.76 HTR3E (0.59) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL2273801 0.75 ADRB1 (0.58) ADRB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL8318076 0.74 CHRM2 (0.57) ADRB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL1252295 0.74 CHRM2 (0.57) ADRB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL14336964 0.74 ADRB1 (0.57) ADRB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL2835955 0.74 ADRB1 (0.57) ADRB1CHRM2CHRM4CHRM1CHRM3
Hydrochloric Acid SCHEMBL6965885 0.73 ADRB1 (0.96) ADRB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL4074110 0.71 MAOB (0.40) ADRB1FFAR4TP53HTR1ASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6110939-A AS A SUBSTANCE P ANTAGONISTS TREATING TACHYKININ-MEDIATED DISEASE, ASTHMA, CENTRAL NERVOUS SYSTEM DISORDER JANSSEN PHARMACEUTICA N.V. (BE) 2000-08-29 US disclosed